We create medical extended reality (MXR) apps at Cedars-Sinai using an iterative methodology. Our therapeutic software is rigorously developed and validated using a three-phase process, summarized below (read more):
VR1 studies focus on content development by working with patient and provider end-users through principles of human-centered design.
VR2 trials conduct early testing with a focus on feasibility, acceptability, tolerability, and initial clinical efficacy.
VR3 trials are randomized controlled trials that compare clinically important outcomes between intervention and control condition.
VR Solace was designed to distract people from pain and help them relax. Choose to virtually travel to one of eight beautiful and unique scenes. Along with soothing music and tranquil sound effects, unexpected delights keep things interesting and engaging. Watch the video, below, for a montage of scenes from VR Solace. We are currently testing this app in our NIH sponsored study of virtual reality for chronic GI cancer pain (read more).
Irritable bowel syndrome (IBS) affects nearly 10% of the world’s population and undermines physical, emotional and social wellbeing. Although medical treatments can be effective, research shows that mind-body treatments such as meditation, cognitive behavioral therapy, and biofeedback can boost quality of life, reduce visceral anxiety, and promote healthy living for people suffering from IBS. Using the latest in virtual reality technology, coupled with the science of mind-body medicine, IBS/VR surrounds each user within virtual environments designed to strengthen the brain-gut axis and improve quality of life.
Instead of patients always reporting to the clinic, with IBS/VR the clinic comes to the patient. From the comfort of their own home, patients explore a virtual clinic with specialized treatment rooms unlike anything possible in an ordinary clinic.